NEW YORK ( TheStreet) -- Novo Nordisk A/S (NYSE: NVO) hit a new 52-week high Tuesday as it is currently trading at $151.20, above its previous 52-week high of $151.16 with 240,127 shares traded as of 2:55 p.m. ET. Average volume has been 312,200 shares over the past 30 days. Novo Nordisk A/S has a market cap of $84.1 billion and is part of the health care sector and drugs industry. Shares are up 29.3% year to date as of the close of trading on Monday. Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products in Denmark and internationally. The company operates in two segments, Diabetes Care and Biopharmaceuticals. The company has a P/E ratio of four, below the average drugs industry P/E ratio of 27.7 and below the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter